Axed Vaccine Chief Reveals RFK Jr.’s Crackpot ‘Data’ Demands
Dr. Peter Marks is being forced to resign from the FDA because the Trump administration does not want someone who is ...
Ousted Vaccine Official Says Kennedy Sought Data to Justify Anti-Science Stance, WSJ Reports
(Reuters) -Peter Marks, the FDA's top vaccine official ousted by Robert F. Kennedy Jr. said the U.S. health secretary's team ...
Novavax call volume above normal and directionally bullish
Bullish option flow detected in Novavax (NVAX) with 12,673 calls trading, 2x expected, and implied vol increasing almost 14 points to 90.76%.
Endpoints News10h
No­vavax’s held-up ap­proval pack­age may sig­nal warn­ing for Covid vac­cine mak­ers
On the precipice of FDA approval, Novavax's Covid vaccine is now in limbo while a decision to approve or reject it is held up ...
Fierce Pharma14h
GSK, Pfizer resolve RSV patent feud amid vaccine market uncertainty
As the respiratory syncytial virus (RSV) vaccine field grapples with a significantly reduced market size thanks to regulatory ...
FDA Delays Final Approval of Novavax COVID Vaccine
The delay dovetails with moves by Republican lawmakers in at least seven states to ban or limit mRNA vaccines. Some, according to KFF Health News, are also pressing regulators to revoke federal ...
Science-Based Medicine17hOpinion
Doctors Who Fluffed RFK Jr.: Here’s What You Own So Far
"Just where is that extensive 5000 word longform apology from Adam Cifu over at Sensible Medicine, begging forgiveness for ...
The Pharma Letter19h
$175 million milestone in jeopardy as FDA delays Novavax nod
US biotech Novavax (Nasdaq: NVAX) is still waiting on a decision from the Food and Drug Administration over full approval of its protein-based COVID-19 vaccine, despite the agency having set an April ...